Implant dynamics, inner structure, and their impact on drug release of in situ forming implants uncovered through CT imaging.

Autor: Lin X; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, United States of America., Al Zouabi NN; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, United States of America., Ward LE; Department of Radiology, Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America., Zhen Z; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, United States of America., Darji M; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, United States of America., Masese FK; Department of Chemistry, University of Connecticut, Storrs, CT, United States of America., Hargrove D; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, United States of America., O'Reilly Beringhs A; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America., Kasi RM; Department of Chemistry, University of Connecticut, Storrs, CT, United States of America., Li Q; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America., Zhang Q; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America., Qin B; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America., Wang Y; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America., Jay M; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States of America., Yuan H; Department of Radiology, Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America., Lu X; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, United States of America. Electronic address: xiuling.lu@uconn.edu.

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Nov; Vol. 375, pp. 802-811. Date of Electronic Publication: 2024 Oct 04.

Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres.

Autor: Liang D; Department of Pharmaceutical Sciences, The Biointerfaces Institute, University of Michigan, 2800 Plymouth Rd., Ann Arbor, MI, 48109, USA., Walker J; Department of Pharmaceutical Sciences, The Biointerfaces Institute, University of Michigan, 2800 Plymouth Rd., Ann Arbor, MI, 48109, USA., Schwendeman PS; Department of Electrical Engineering and Computer Science, University of Michigan, 1301 Beal Ave., Ann Arbor, MI, 48109, USA., Chandrashekar A; Department of Pharmaceutical Sciences, The Biointerfaces Institute, University of Michigan, 2800 Plymouth Rd., Ann Arbor, MI, 48109, USA., Ackermann R; Department of Pharmaceutical Sciences, The Biointerfaces Institute, University of Michigan, 2800 Plymouth Rd., Ann Arbor, MI, 48109, USA., Olsen KF; Department of Pharmaceutical Sciences, The Biointerfaces Institute, University of Michigan, 2800 Plymouth Rd., Ann Arbor, MI, 48109, USA., Beck-Broichsitter M; MilliporeSigma a Business of Merck Life Science KGaA, Frankfurter Strasse 250, D-64293, Darmstadt, Germany., Schwendeman SP; Department of Pharmaceutical Sciences, The Biointerfaces Institute, University of Michigan, 2800 Plymouth Rd., Ann Arbor, MI, 48109, USA. schwende@med.umich.edu.; Department of Biomedical Engineering, University of Michigan, 2800 Plymouth Rd., Ann Arbor, MI, 48109, USA. schwende@med.umich.edu.

Publikováno v: Drug delivery and translational research [Drug Deliv Transl Res] 2025 Jan; Vol. 15 (1), pp. 185-202. Date of Electronic Publication: 2024 Apr 20.

Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective.

Autor: Rezaee M; Student Research Committee, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Fars, Iran; Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Fars, Iran., Karimzadeh I; Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran., Hashemi-Meshkini A; Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy and Evidence-Based Medicine Group, Tehran University of Medical Sciences, Tehran, Tehran, Iran., Zeighami S; Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Fars, Iran., Bazyar M; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran., Lotfi F; Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Fars, Iran., Keshavarz K; Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Fars, Iran; Emergency Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Fars, Iran. Electronic address: khkeshavarz2007@gmail.com.

Publikováno v: Value in health regional issues [Value Health Reg Issues] 2024 Jul; Vol. 42, pp. 100982. Date of Electronic Publication: 2024 Apr 24.

Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.

Autor: Tutrone R; Chesapeake Urology, Towson, MD, USA. Electronic address: rtutrone@uniteduro.com., Saad F; University of Montreal Hospital Centre, Montreal, QC, Canada., George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Tombal B; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium., Bailen JL; First Urology, Jeffersonville, IN, USA., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Saltzstein DR; Urology San Antonio, San Antonio, TX, USA., Hanson S; Pfizer, Inc., New York, NY, USA., Brown B; Myovant Sciences, Inc., Brisbane, CA, USA., Lu S; Myovant Sciences, Inc., Brisbane, CA, USA., Fallick M; Myovant Sciences, Inc., Brisbane, CA, USA., Shore ND; Carolina Urologic Research Center and GenesisCare USA, Myrtle Beach, SC, USA.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 906-913. Date of Electronic Publication: 2023 Dec 23.

Timing of onset of menses after GnRH agonist treatment for central precocious puberty.

Autor: Klein KO; Rady Children's Hospital, San Diego, CA, USA.; Department of Pediatrics, University of California, San Diego, CA, USA., Vargas Trujillo M; Rady Children's Hospital, San Diego, CA, USA.; Department of Pediatrics, University of California, San Diego, CA, USA., Dragnic S; AbbVie, North Chicago, IL, USA., Van Komen S; AbbVie, North Chicago, IL, USA., Li M; AbbVie, North Chicago, IL, USA., Lee PA; Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Penn State Hershey Medical Center, Hershey, PA, USA.

Publikováno v: Journal of pediatric endocrinology & metabolism : JPEM [J Pediatr Endocrinol Metab] 2024 Apr 15; Vol. 37 (5), pp. 451-461. Date of Electronic Publication: 2024 Apr 15 (Print Publication: 2024).